Fragile X-Related Proteins Regulate Mammalian Circadian Behavioral Rhythms  by Zhang, Jing et al.
ARTICLEFragile X-Related Proteins Regulate
Mammalian Circadian Behavioral Rhythms
Jing Zhang,1 Zhe Fang,1 Corinne Jud,2 Mariska J. Vansteensel,3 Krista Kaasik,4 Cheng Chi Lee,4
Urs Albrecht,2 Filippo Tamanini,5 Johanna H. Meijer,3 Ben A. Oostra,6 and David L. Nelson1,*
Fragile X syndrome results from the absence of the fragile Xmental retardation 1 (FMR1) gene product (FMRP). FMR1 has two paralogs in
vertebrates: fragile X related gene 1 and 2 (FXR1 and FXR2). Here we show that Fmr1/Fxr2 double knockout (KO) and Fmr1 KO/Fxr2 het-
erozygous animals exhibit a loss of rhythmic activity in a light:dark (LD) cycle, and that Fmr1 or Fxr2 KO mice display a shorter free-
running period of locomotor activity in total darkness (DD). Molecular analysis and in vitro electrophysiological studies suggest
essentially normal function of cells in the suprachiasmatic nucleus (SCN) in Fmr1/Fxr2 double KO mice. However, the cyclical patterns
of abundance of several core clock component messenger (m) RNAs are altered in the livers of double KO mice. Furthermore, FXR2P
alone or FMRP and FXR2P together can increase PER1- or PER2-mediated BMAL1-Neuronal PAS2 (NPAS2) transcriptional activity in
a dose-dependent manner. These data collectively demonstrate that FMR1 and FXR2 are required for the presence of rhythmic circadian
behavior in mammals and suggest that this role may be relevant to sleep and other behavioral alterations observed in fragile X patients.Introduction
Fragile X syndrome (FXS [MIM #300624]) is the most com-
mon form of inherited mental retardation, with an esti-
matedprevalenceof 1 in4000males and1 in8000 females.1
Typical fragile X patients display physical and behavioral
abnormalities, suchas a long,narrowface, large ears,macro-
orchidism, cognitive impairment, hyperactivity, and autis-
tic behaviors.2 The common form of this syndrome is
caused by an expansion mutation of a CGG triplet repeat
in the 50 UTR of the FMR1 gene, which transcriptionally
silences the gene and leads to loss of FMRP.3 FMRP is an
RNA-binding protein that associates with translating poly-
ribosomes.4–6 Fmr1mRNA and FMRP are expressed ubiqui-
tously, particularly the brain and testes.7
FMRP (MIM *309550), FXR1P (MIM *600819), and
FXR2P (MIM *605339) compose a small family of RNA-
binding proteins (fragile X-related protein family; FXR
family).8,9 These three proteins share >60% amino acid
identity and are able to form homo- and heterotypic inter-
actions with each other.9,10 It has been postulated that the
presence of FXR1P and FXR2P could partially compensate
for the loss of FMRP in the fragile X syndrome. Drosophila
has a single gene, Drosophila FMR1 (dfmr1) or Drosophila
Fmr1-related gene (dfxr), whose product shares sequence
identity and biochemical properties with the fragile X-
related protein family.11 To unravel the molecular and cel-
lular bases of fragile X syndrome and to explore therapeu-
tic strategies, bothDrosophila andmousemodels have been
produced. We and others tested dfmr loss-of-function ﬂies
and found altered circadian behavior without detectable
alteration in central clock components.12,13 The disturbedactivity-rest cycle of the ﬂy, together with the observed
sleep disorders in fragile X patients,2,14 led us to investigate
circadian behavior in mice with viable mutations in mem-
bers of the FXR family.15,16
In this study, we demonstrate that mice lacking FMRP or
FXR2P display a shorter free-running period of locomotor
activity in total darkness. In the absence of both proteins,
completely arrhythmic activity was observed in animals
maintained in a light:dark cycle. This arrhythmic pheno-
type is unique among circadian defects described in mouse
models to date. Interestingly, in the absence of FMRP/
FXR2P, the cyclical patterns of abundance of several core
clock component mRNAs are altered in the liver, which
contains a major peripheral clock. By using an in vitro
luciferase transfection assay, we observed that FXR2P alone
or FMRP and FXR2P together can increase PER1- or
PER2-mediated BMAL1-NPAS2 transcriptional activity in
a dose-dependent manner. These data collectively demon-
strate that FMR1 and FXR2 are required for the presence of
behavioral circadian rhythms and indicate that this role
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Experimental animals were continuously provided with food and
water. Wheel-running activity was recorded by a computer data-
acquisition system (Chronobiology kit, Stanford Software Sys-
tems). Animals were maintained on a 12:12 light/dark cycle for
2 weeks and then were transferred to constant darkness for at least
2 weeks. The raw activity data can be visualized and analyzed with
a c2 periodogram (Chronobiology kit). The data were plotted in
double plot activity histograms. The free-running period, t, and
total activity were analyzed with the Chronobiology kit.
In Situ Hybridization
Adult wild-type (6- to 10-month-old), Fmr1 mutant, Fxr2 mutant,
and Fmr1/Fxr2 double mutant mice were maintained in 12:12 LD
cycle for 2 weeks and then released into DD. At 36th, 42nd, 48th,
and 54th hour in the constant darkness, the mice were sacriﬁced
for the experiments. Specimen preparation and in situ hybridiza-
tion were carried out as described previously.17 In brief, the
[35S]UTP (1250 Ci/mmol, PerkinElmer)-labeled riboprobes were
synthesized with the RNAMaxx High Yield transcription kit (Stra-
tagene) according to manufacturer’s protocol. The mBmal1 probe
was made from a cDNA corresponding to nucleotides (nt) 654–
1290 (accession number AF015953), mCry1 corresponds to nt
190–771 (AB000777), mPer1 to nt 620–1164 (AF022992), and
mPer2 to nt 229–768 (AF036893). 7 mm thick parafﬁn sections
were dewaxed, rehydrated, and ﬁxed in 4% paraformaldehyde.
Sections were then permeabilized with a proteinase K (Roche)
digestion before they were ﬁxed again and acetylated. After serial
dehydration, hybridization was performed overnight at 55C in
a humid chamber. Stringency washes were carried out at 63C.
Slides were subjected to a ribonuclease A (Sigma) digestion and
then dehydrated in graded ethanol series. Quantiﬁcation was per-
formed by densitometric analysis (GS-700 or GS-800, BioRad) of
autoradiography ﬁlms (Amersham Hyperﬁlm) with the Quantity
One software (BioRad). Data from the SCN were normalized by
subtracting the optical density measured in the lateral hypothala-
mus next to the SCN. For each experiment, 2 animals per genotype
were used and 4 to 9 adjacent SCN sections per animal were ana-
lyzed. Relative RNA abundance values were calculated by deﬁning
the highest wild-typemean value of each experiment as 100%. For
statistical analysis, two-way ANOVA with Bonferroni post-test
(GraphPad Prism software) was performed.
In Vitro Electrophysiology
The multiunit electrical activity rhythms of SCN neurons were re-
corded as described previously.18 In short, brains of WT, Fmr1 KO,
and Fmr1/Fxr2 double KO mice were rapidly dissected from the
skull at the same Zeitgeber times (1.7 hr to 2.4 hr after lights
on). Coronal hypothalamic slices that contained the SCN were
sectioned and transferred to an interface chamber. Slices were
oxygenated with humidiﬁed 95% O2/5% CO2 and perfused with
artiﬁcial cerebrospinal ﬂuid (ACSF) at 35C. We used one slice
per animal and attempted simultaneous recordings of multiunit
neuronal activity from the dorsal and ventral SCN with two
stationary electrodes.
Northern Blot Analysis
Liver total RNA was isolated by guanidinium isothiocyanate ex-
traction and CsCl centrifugation19 from adult wild-type (6- to
10-month-old), Fmr1mutant, Fxr2mutant, and Fmr1/Fxr2 double
mutant mice. These animals were maintained in 12:12 LD cycle
for 2 weeks and then released into DD for at least 24 hr. For all44 The American Journal of Human Genetics 83, 43–52, July 2008northern blot analyses, 25 mg of total RNA was separated on
1.2% agarose-formaldehyde gels and transferred to nylon mem-
branes. The UV crosslinked membranes were hybridized with
32P-labeled cDNA probes for Bmal1, Clock, Per1, Per2, Cry1,
Npas2, andActin according to the instructions of themanufacturer
(BD Biosciences). To calculate relative RNA abundance, optical
densities of Bmal1, Clock, Per1, Per2, Cry1, andNpas2 hybridization
were divided by densities from Actin hybridization to the same
blot. Normalized values were then averaged for the blots prepared
from different sets of RNA samples.
Real-Time PCR
The same RNA isolated for northern blot analysis was also used for
real-time PCR analysis. To prepare cDNA, 1–3 mg total RNA was re-
verse-transcribed with random primers at a ﬁnal concentration of
3 mM MgCl2, 75 mM KCl, and 50 mM Tris-HCl (pH 8.3), 1 mM
each of dNTPs, 10 units of RNase inhibitor, and 100 units of Super-
script II Rnase Hreverse transcriptase (Invitrogen). The reaction
mixture was incubated at 37C for 60 min. Real-time PCR was
performed with the ABI PRISM 7000 Sequence Detector System
(SDS) (Applied Biosystems) and MicroAmp optical 96-well plates
(Applied Biosystems). Gene expression assays were performed
with commercially available Pre-made TaqMan Gene Expression
assays for eight genes. The speciﬁc Pre-made TaqMan Gene Ex-
pression assays used in this study were: Bmal1 (Applied Biosys-
tems, Assay ID: Mm00500226_m1), Clock (Mm00455950_m1),
Per1 (Mm00501813_m1), Per2 (Mm00478113_m1), Cry1
(Mm00514392_m1), and Npas2 (Mm00500848_m1). Eukaryotic
18S rRNA (Applied Biosystems 4333760T) was used as endogenous
control. The thermocycling proﬁle for all PCR reactions began
with 1 cycle of 2min at 50C and 10min at 95C andwas followed
by 40 cycles of 15 s at 95C and 1 min at 60C. All samples were
run in triplicate.
Dual Luciferase Reporter Assays
Transient transfection was carried out with the Lipofectamine2000
reagent (Invitrogen) according to the manufacturer’s instructions.
In brief, 1 3 105 HeLa cells were seeded in each well of a 24-well
tissue culture plate. The cells were incubated until 85%–90% con-
ﬂuence. Cells in each well were transfected with 10 ng of the
mPer1-luc or 40 ngmPer2-luc reporter construct. Expression vectors
for BMAL1, CLOCK, NPAS2, PER1, PER2, CRY1, FMR1, and FXR2
were cotransfected respectively. The renilla luciferase reporter
pRL-TK plasmid (Promega) was cotransfected as an internal con-
trol. The pcDNA3.1 (Invitrogen) vector was used to bring the total
amount of plasmid DNA to 0.8 mg/well. Transfection was done
with Lipofectamine2000 reagent. After transfection for 18 hr, cells
were collected and lysed and the ﬁreﬂy and renilla luciferase activ-
ity were measured with Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s instructions with
a TD-20e luminometer (Turner designs).
Results
Fmr1 or Fxr2 KO Mice Display a Shorter Free-Running
Period of Locomotor Activity in DD
To determine whether mutations in the fragile X-related
protein family alter circadian behavior, we measured the
circadian wheel-running activity of Fmr1 knockout (Fmr1
KO) mice, Fxr2 knockout (Fxr2 KO) mice, and of their
wild-type (WT) littermates individually in circadian activ-
ity-monitoring chambers. Mice were initially maintained
in a 12 hr light:12 hr dark (12:12 LD) cycle for 2 weeks to
establish entrainment. After release in constant darkness
(DD), the WT animals showed a free-running period (tau
or t) of slightly less than 24 hr (t ¼ 23.885 0.05; n ¼ 12)
(Figure 1A). Fmr1 and Fxr2 knockout mice displayed signif-
icantly shorter circadian periods than their WT littermates
in DD (t¼ 23.715 0.06, p< 0.01; n¼ 18; and t¼ 23.565
0.05, p< 0.01; n¼ 28; respectively) (Figures 1B and 1C; for
all tau values, see Figure S1A available online). These ﬁnd-
ings suggest that FMRP and FXR2P affect the period length
of the circadian system. Under LD conditions, Fmr1 and
Fxr2 knockout mice were entrained by light (Figures 1B
and 1C), suggesting that a deﬁciency in either gene alone
does not produce a detectable loss of entrainment of loco-
motor activity.
Fmr1/Fxr2 Double KO and Fmr1 KO/Fxr2
Heterozygous Mice Exhibit a Loss of Rhythmic
Activity in Both LD and DD
Because Fmr1 knockout mice express FXR2P at normal
levels (and vice versa), functional redundancy may blur
phenotypic outcomes in single KO animals. It was of in-
terest, therefore, to examine Fmr1/Fxr2 double knockout
mice, which are viable and do not exhibit major physical
defects.20 Unexpectedly, the locomotor activity patterns
of these double mutant animals not only exhibited a strik-
ing and complete loss of circadian rhythm in constant
darkness but were also arrhythmic under LD cycles (Figures
Figure 1. Representative Locomotor Activity Records of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1/Fxr2 Double KO Mice
(A) Representative locomotor activity records of WT mice.
(B) Representative locomotor activity records of Fmr1 KO mice.
(C) Representative locomotor activity records of Fxr2 KO mice.
(D–F) Representative locomotor activity records of Fmr1/Fxr2 double KO mice. Activity records are double-plotted, so that 48 hr is shown
on each horizontal trace with a 24 hr day presented both beneath and to the right of the preceding day. Times of activity are indicated by
black vertical marks. All records show activity in wheel running activity during exposure to a 12:12 light/dark cycle and after release into
constant darkness (as indicated by the LD/DD in the margin). The slope of the line (in red) aligned with the points of onset of activity on
a 24 hr scale plot reflects the period length in DD. The open and dark rectangles at the top of the figure indicate the LD cycle during
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1D–1F, n ¼ 12; for more samples from double KOmice un-
der LD conditions, see Figures S2A–S2D). Chi-square perio-
dogram analysis in LD for double knockout mice showed
no measurable circadian rhythm (Figures S2E–S2H). Inter-
estingly, Fmr1 knockout mice that were heterozygous for
the Fxr2 mutation (n ¼ 8) also demonstrated wheel-
running patterns that were largely comparable to double-
knockout mice (Figures S2I–S2P), with weakly cyclical
activity in LD that does not appear to be synchronized to
the 24 hr period. Apparently, in the absence of FMR1,
half normal levels of FXR2 are inadequate to establish en-
trainment in the LD cycle. Because the average levels of
wheel-running activity did not differ signiﬁcantly (p >
0.05 by one-way ANOVA) among the four genotypes in
DD (wheel rotations per day for WT, Fmr1, Fxr2, and dou-
ble knockout mice are 26,512 5 2,898; 27,924 5 2,378;
26,735 5 1,836; and 23,980 5 2,798, respectively), the
absence of a circadian rhythm cannot be explained by
a change in total activity.
Our behavioral experiments demonstrate that disrup-
tion of either of the two fragile X mental retardation genes
results in alterations of circadian period, and combined
disruption of both results in arrhythmicity in behavior.
Light and visual perception in double KO mice are
normal20 and no abnormalities could be detected in the
eyes of these animals by histology (data not shown). These
results indicate that FXRPs function in the mammalian
circadian clock or act downstream in the control of
activity.
Molecular Analysis and In Vitro Electrophysiological
Studies Suggest Normal SCN Function
in the Fmr1/Fxr2 Double KO Mice
To investigate whether the behavioral differences between
the three knockout strains and their WT littermates might
be due to a defect in the central circadian pacemaker, we
examined clock gene expression in the suprachiasmatic
nucleus (SCN) of the brain. Figure 2 illustrates expression
of clock gene mRNAs (Per1, Per2, Bmal1, and Cry1) in the
mouse SCN by in situ hybridization. The expression of
Per1, Per2, Bmal1, and Cry1 was rhythmic in the SCN
over 24 hr in constant darkness (Figure 2). Signiﬁcant
quantitative differences were observed between genotypes.
For example, Fmr1/Fxr2 double knockout animals showed
an increased level of Cry1 expression at CT12, which coin-
cides with the predicted time of light off (Figure 2D). None-
theless, the overall pattern of clock gene expression in the
SCN appears unchanged between animals of different ge-
notypes. We also investigated the electrical activity of the
SCN pacemaker of WT, Fmr1 KO (n ¼ 6), and Fmr1/Fxr2
double KO (n ¼ 7) mice. Electrical activity is controlled
by the core clock and serves as a major output signal of
the SCN. We found that the SCN electrical activity shows
high amplitude circadian rhythmicity in WT (data not
Figure 2. Expression Analysis of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1/Fxr2 Double KO under DD Conditions in SCN
In situ hybridization results for brains isolated from WT and the three knockout genotypes sacrificed at four different time points for Per1
(A), Per2 (B), Bmal1 (C), and Cry1 (D) mRNA levels of Per1, Per2, Bmal1, and Cry1 were quantified and normalized. Graphs illustrate
the relative transcript level of these four genes. The largest value of WT is normalized to 100%. Error bars indicate the SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. CT, circadian time.46 The American Journal of Human Genetics 83, 43–52, July 2008
shown), Fmr1 KO (Figure 3A), and Fmr1/Fxr2 double KO
(Figures 3B–3D) mice, with no signiﬁcant differences in
peak time (p> 0.2). Preparation of slices 12 hr out of phase
from Fmr1/Fxr2 double KO animals results in similar peak
time (data not shown). Our molecular and in vitro electro-
physiological data suggest that the SCN pacemaker is in-
tact in knockout animals and that behavioral differences
observed between wild-type and Fmr1 KO, Fxr2 KO, and
Fmr1/Fxr2 double KO animals are unlikely to result from
a deﬁciency in the SCN but could be caused by a deﬁciency
downstream of the SCN pacemaker.
The Cyclical Patterns of Abundance of Several Core
Clock Component mRNAs Are Altered in the Liver
of Double KO Mice
When we examined the mRNA levels in the liver, which is
probably the best described peripheral clock in mammals,
we observed a substantial change in clock gene expression
in knockout animals. Expression of Bmal1 in the livers of
double knockout mice is decreased at CT0 (Figures 4A,
4B, and 5A; Figures S3A and S3G). Compared to WT mice,
mPer1 expression in the liver of Fxr2 and Fmr1/Fxr2 double
mutants is signiﬁcantly increased at CT6 (p< 0.01 for both
genotypes, Figures 4A, 4B, and 5C; Figures S3C and S3G). It
is also notable that the distributions of levels of mPer1 ex-
pression are much wider at CT6 and CT12 in the liver of
Fxr2 and Fmr1/Fxr2 double knockout mice (Figure 5C;
Figure S3C). mPer2 expression in the liver peaks approxi-
mately 6 hr earlier in Fmr1/Fxr2 double mutants compared
to Fmr1 knockout or WT animals (Figures 4A, 4B, and 5D;
Figures S3D and S3G). Similar to mPer1, the variations of
mPer2 expression levels at CT6 in the liver of Fxr2 and
Fmr1/Fxr2 double knockout mice are much more broad
than those in WT animals (Figure 5D; Figure S3D). The ex-
pression of Cry1 is signiﬁcantly increased at CT12 in the
Figure 3. Representative Recordings of SCN Electrical
Activity in Fmr1 KO and Fmr1/Fxr2 Double KO Mice
(A) Representative recordings of SCN electrical activity in Fmr1
KO mice.
(B–D) Representative recordings of SCN electrical activity in
Fmr1/Fxr2 double KO mice. The electrical activity traces are
individual examples of neuronal ensemble recordings. The
open and dark rectangles at the top of the figure indicate the
LD cycle to which the animals were entrained before slice prep-
aration, and time is indicated on the x axis. The electrical
activity is counted per 10 s and presented on the y axis.
MUA, multiunit electrical activity.
livers of both double and either of the single KO mice
(Figures 4A, 4B, and 5E; Figures S3E and S3G). Clock,
which does not cycle in WT animals, was not signiﬁ-
cantly altered in the livers of the mutants (Figures 4A,
4B, and 5B; Figures S3B and S3G).
Npas2, a transcription factor that is highly similar to
Clock, heterodimerizes with Bmal1 and activates Per
transcription.21,22 BecauseClock expressionwas indistin-
guishable between WT and mutants, we tested the expres-
sion of Npas2 transcript in the liver (Npas2 expression can-
not be detected by in situ hybridization in the SCN). Npas2
expression in Fmr1 mutants is similar to that in WT. How-
ever, Npas2 expression in Fxr2mutants is slightly increased
at CT18 and signiﬁcantly decreased at CT0. In double mu-
tants, Npas2 expression peaks at CT18, whereas it peaks at
CT0 in WT controls (Figures 4A, 4B, and 5F; Figures S3F
and S3G). This indicates that in the absence of Fxr2, Npas2
expression is altered and that Fmr1 has an additive effect
on Npas2 cycling. These data suggest that the loss of FMRP,
FXR2P, or both affects peripheral circadian clock function.
FXR2P Alone or FMRP and FXR2P Together Can
Increase PER1- or PER2-Mediated BMAL1-NPAS2
Transcriptional Activity in a Dose-Dependent Manner
Todeterminewhether FMRPandFXR2Pcandirectly regulate
clock gene expression, we performed a luciferase reporter
assay in HeLa cell transfection assays. Initial studies showed
that addition of mPER2 enhanced BMAL1-NPAS2-depen-
dent transcription from either mPer1 or mPer2 promoter as
previouslydescribed.23CoexpressionofFXR2Por the combi-
nation of FMRP and FXR2P together signiﬁcantly enhanced
the mPER2-induced BMAL1-NPAS2 transcriptional activ-
ity from both promoters (Figures 6A and 6B). Similarly,
mPER1-induced BMAL1-NPAS2 transcription from the
mPer1 promoter is further activated by FXR2P or FMRP and
FXR2P together (Figure 6C). Furthermore, this effect on tran-
scriptional stimulationwas dependent on the dose of FXRPs
(Figures S5A and S5B), which agrees with the observations
that FMRP functions in a dose-dependent manner in ﬂies,
mice, and human patients.13,24,25 However, coexpression
of FMRP or FXR2P or both together was not found to inﬂu-
ence CRY1 repression of BMAL1-NPAS2 stimulation (Figures
S4A and S4B). Interestingly, similar transfection studies withThe American Journal of Human Genetics 83, 43–52, July 2008 47
BMAL1-CLOCK showed no stimulation by either FMRP or
FXR2P or by both together (data not shown). Our data indi-
cate that FMRP and FXR2P have direct inﬂuence on themo-
lecular clock feedback loop and that these effects are medi-
ated by the BMAL1-NPAS2 rather than the BMAL1-CLOCK
complex. Based on these ﬁndings and on our observations
Figure 4. Expression Analysis of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1/Fxr2 Double KO Mice under DD Conditions in Liver
(A) Northern blotting results on liver tissues of WT and three different knockout mouse genotypes sacrificed at four different time points.
The probes are indicated on the right. Rehybridization of the same filter with an actin probe was used to control for loading and RNA
integrity. Representative results are shown from one out of four sets of WT, three sets of Fmr1 KO, four sets of Fxr2 KO, and five sets
of Fmr1/Fxr2 double KO mice. Each set of animals represents an independent experiment.
(B) RNA levels of Bmal1, Clock, Per1, Per2, Cry1, and Npas2 were quantified and normalized in reference to actin mRNA levels. The largest
value of WT is normalized to 100%. Graphs illustrate the relative transcript level of these six genes. Error bars indicate the SEM. *p< 0.05,
**p < 0.01.48 The American Journal of Human Genetics 83, 43–52, July 2008
that Npas2 expression is altered signiﬁcantly in the livers of
Fxrmutant animals, we propose thatNPAS2 plays an impor-
tant role in the effects of the fragile X gene family on periph-
eral circadian oscillators and behavioral activity patterns.
Discussion
Circadian rhythmicity is a fundamental biological phe-
nomenon in living organisms. Among animals, the fruit
Figure 5. Expression Analysis of Four Sets of Wild-Type, Three Sets of Fmr1 KO, Four Sets of Fxr2 KO, and Five Sets of Fmr1/Fxr2
Double KO Mice under DD Conditions in Liver
RNA levels of Bmal1 (A), Clock (B), Per1 (C), Per2 (D), Cry1 (E), and Npas2 (F) were quantified and normalized in reference to actin mRNA
levels. The data on relative mRNA abundance were averaged across different time points. Error bars indicate the SEM.The American Journal of Human Genetics 83, 43–52, July 2008 49
Figure 6. Upregulation of BMAL1-NPAS2-Mediated Transcrip-
tion by FMR1 and FXR2 in the Presence of mPER1 or mPER2
(A) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer1 promoter by FMR1 and FXR2 in the presence of mPER2.
(B) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer2 promoter by FMR1 and FXR2 in the presence of mPER2.
(C) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer1 promoter by FMR1 and FXR2 in the presence of mPER1.
HeLa cells were cotransfected with the reporter construct mPer1-
luc or mPer2-luc and control reporter construct Renilla luciferase50 The American Journal of Human Genetics 83, 43–52, July 2008ﬂy and the mouse have provided the most information on
themechanism of central circadian pacemakers. These spe-
cies’ clocks share conserved gene products, although there
are signiﬁcant differences between the explanatory models
for maintenance of rhythmicity.26 In the ﬂy, loss-of-func-
tion mutations of the dfmr gene have been shown to alter
circadian behavior without detectably affecting the func-
tion of the central pacemaker, suggesting a role for dfmr
in circadian output.12,13 In the mouse, CLOCK, BMAL1,
PER, and CRYare core components of the circadian oscilla-
tory mechanisms. The active CLOCK-BMAL1 complex
drives expression of numerous genes including PER and
CRY, whereas PER and CRY repress CLOCK-BMAL1 tran-
scriptional activities and therefore form a feedback regula-
tion loop.27,28 Regulation of CLOCK-BMAL1 activity is
central to the mammalian clock. The appropriate delay be-
tween the activation and repression of transcription main-
tains the daily oscillations of clock proteins and gives the
clock a ~24 hr period.29 Here, we report a function for the
Fmr1 and Fxr2 genes in circadian behavior and clock gene
expression in the liver ofmice. Thedramatic circadianactiv-
ity phenotype found in Fmr1/Fxr2 double KO mice is
unprecedented, demonstrating a signiﬁcant role of those
genes in clock function or output. The alterations to clock
genemRNAs in the liver, butnot in themaster clock, suggest
that FMRP and FXR2P are acting downstream of the circa-
dian pacemaker in mammals. CLOCK and NPAS2 have
been shown to have partially redundant functions in the
SCN, with CLOCK having a dominant role.30 Our transfec-
tion data would suggest that the FXR proteins exert effects
on NPAS2/BMAL1 complex rather than CLOCK/BMAL1.
Thus, it is not surprising that the SCN is less affected than
the liver in Fxr mutant animals. The differences between
the SCN and liver of Fxrmutant mice suggest examination
of the roles of FMRP and FXR2P in mice with mutations in
Clock and/or Npas2. Intriguingly, animals lacking both
Clock and Npas2 show rhythmic activity in LD,30 whereas
Fmr1/Fxr2 double knockouts are arrhythmic.
It is worth while to note that in addition to FMRP and
FXR2P, FXR1P, another member of FMR1 gene family, may
play a compensatory role in the absence of Fmr1, Fxr2, or in
Fmr1/Fxr2doubleknockoutmice.Becauseof theearlypostna-
tal death of Fxr1 knockoutmice, a conditional Fxr1 knockout
model was produced.31 These mice exhibit muscle defects,
but the generation of Fmr1/Fxr1/Fxr2 triple mutant mice
should providemore information onpotential functional in-
teractions in circadian clock regulation andmay offer amore
direct comparison to the Drosophila loss-of-function model,
where a single FMR1-like protein may perform many of the
functions distributed among the three mammalian genes.
The neural connections between the SCN and other parts
of the nervous system are important for the control of
encoding plasmids PRL-TK and various combinations of expression
construct (Material and Methods). Luciferase activity in samples
transfected with reporter constructs only is adjusted as 1.0. Error
bars indicate the SD (n ¼ 4).
circadian rhythms in the central nervous system.32 Interest-
ingly, it has been shown that the absence of FMRP causes ab-
normal neurotransmitter signaling, which could be respon-
sible forneurological deﬁciencies in fragileX syndrome.33,34
It is possible, therefore, that the loss of FMRP and FXR2P
results in arrhythmicity resulting from inappropriateneuro-
nal communication within the central nervous system.
A link between abnormal sleep patterns andmental retar-
dation has been suggested from several other mental retar-
dation disorders,35 including Smith-Magenis syndrome,36
where the RAI1 transcriptional activator appears to be ama-
jor contributor to phenotype. To our knowledge, our data
provide the ﬁrst molecular evidence to connect a protein
involved in cognitive ability with the circadian system. Al-
though sleep abnormalities are a frequent feature in males
with fragile X syndrome, the level of severity varies signiﬁ-
cantly in different patients.2,14 Our data that in the absence
of Fmr1, losinghalf normal levels of Fxr2 can result in loss of
light-dark entrainment suggest that genetic variation in
Fxr2 could be responsible for the variability of sleep prob-
lems in fragile X population. Sleep abnormality could add
to the phenotype; several lines of evidence suggest a role
for normal sleep in learning and memory.37 The close
association between the circadian system and the timing
of sleep and wakefulness together with the typical distur-
bances of circadian behavior and sleep in fragile X syn-
drome opens up a new perspective for the investigation
and treatment of patients suffering from this disorder.
Supplemental Data
Five ﬁgures are available at http://www.ajhg.org/.
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